The short interest data is out for the July 31 settlement date. We often review the higher-yield defensive dividend stocks for a barometer of what short sellers may be thinking. The trends…
With interest rates still at historic lows, the stock market is ultimately the only destination for investor capital, and dividend-paying stocks make good sense in volatile markets.
Drug giants Merck and Pfizer reported better-than-expected second-quarter 2014 results before markets opened Tuesday morning.
The short interest data for the July 15 settlement date is out and we have compared the defensive dividend stocks, aside of utilities, to what has happened since the June 30 settlement…
Wikimedia CommonsIn a week that saw more than its share of volatility some top insiders decided it was time to lighten up on their holdings. As we have mentioned in the past,…
The short interest data for the June 30 settlement date is out, and there were selectively an increasing number of shares short in our go-to list of defensive high-yield stocks that are…
The second quarter of 2014 has come and gone, which means that we are now already half way through 2014. The five-year bull market has managed to continue making its gains. The…
The short interest data for the first two weeks of June show that short interest was higher in almost all our go-to list of defensive high-yield stocks that are not utilities.
ThinkstockThe short interest data for the final two weeks of May have been released, and the results are somewhat surprising when it comes to the top high-yield safe dividends we follow. Some…
Here are the four top biotech names we found that all have hepatitis C drugs in their current pipelines at one stage or another and that could be the next takeover targets.
24/7 Wall St. wanted to look at the leaders and laggards in the Dow Jones Industrial Average. It turns out that as of Friday's closing bell, seven of the 30 Dow stocks…
thinkstockMay 29, 2014: Markets opened higher on Thursday following reports that U.S. GDP contracted by 1% in the first quarter and that new claims for jobless benefits fell to 300,000. Pending home…
Pfizer looks like it is out of the bid now for AstraZeneca. What looks increasingly obvious for a lackluster performance is that Pfizer may now simply be having an identity crisis.
thinkstockMay 8, 2014: Markets opened lower on Thursday and posted solid gains on a good report on new claims for jobless benefits. Momentum stocks lost their get-up-and-go in the afternoon, though, and…
These are the top Wall Street analyst upgrades, downgrades and initiations for Thursday, May 8, 2014. They include Chevron, Exxon, FedEx, Merck, Tesla, Twitter, Disney and Yelp.
